CASI Pharmaceuticals (CASI) Q2 2025 Earnings

16MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.75
-0.67
-0.6
-0.52

Details

Expected EPS
-0.61
Actual EPS
-0.69
Surprise EPS
-0.08
Surprise Percent
+13.11%

Description

CASI Pharmaceuticals (CASI) has reported earnings of -0.69 per share for Q2 2025.

0 Comments

Share your thoughts